📊Financials 📈PE Ratio 🥧Shareholding 💰Dividend 📋Quarterly ⚖️Balance Sheet 💹P&L 🌊Cash Flow

ZENITHDRUGPharmaceuticals

ZENITH DRUGS LIMIT — Financial Ratios & Key Metrics

₹41.00

+0.00%

P/E Ratio20.98xIndustry: 31.77x

ROE11.11%Return on equity

ROCE12.90%Return on capital

Debt/Equity0.72Low debt

💎

Valuation & Profitability

P/E Ratio

20.98x

Industry Average P/E

31.77x

Dividend Yield

0.00%

Market Cap

₹89.17 (Cr)

Sales Growth 5Y

11.10%

Profit Growth 5Y

16.61%

EPS Growth 5Y

N/A

OPM 5Y Avg

9.94%

📉

Price Returns

1 Month

-20.06%

3 Months

-26.61%

6 Months

-23.47%

1 Year

-44.86%

52W Low

₹38

Current

₹41

52W High

₹107

5% of 52-week range — Near lows

🔬

Technical Indicators

Neutral

Momentum is balanced — neither overbought nor oversold.

SMA 50

₹47

▼ Price below SMA 50 — Bearish

SMA 200

₹59

▼ Long-term downtrend

Volume Signal

91% of avg

Average volume

Technical indicators are for educational purposes only. Not investment advice.

More on ZENITH DRUGS LIMIT

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.